NCT03222622View on ClinicalTrials.gov

Study of Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis

PHASE2TerminatedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

November 29, 2017

Primary Completion Date

August 15, 2018

Study Completion Date

October 26, 2018

Conditions
Mild to Moderate Psoriasis
Interventions
DRUG

Icotinib hydrochloride cream

Apply topically twice daily for 12 consecutive weeks

DRUG

Placebo cream

Apply topically twice daily for 12 consecutive weeks

Trial Locations (1)

310009

The Second Affiliated hospital of Zhejiang University School of Medicine, Hangzhou

Sponsors
All Listed Sponsors
collaborator

Tigermed Consulting Co., Ltd

INDUSTRY

lead

Betta Pharmaceuticals Co., Ltd.

INDUSTRY

NCT03222622 - Study of Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis | Biotech Hunter | Biotech Hunter